Erectile dysfunction: monitoring response to treatment in clinical practice--recommendations of an international study panel
- PMID: 17367440
- DOI: 10.1111/j.1743-6109.2007.00441.x
Erectile dysfunction: monitoring response to treatment in clinical practice--recommendations of an international study panel
Erratum in
- J Sex Med. 2007 May;4(3):825
Abstract
Introduction: Clinical practice guidelines for management of erectile dysfunction (ED) provide limited direction in defining appropriate treatment goals with phosphodiesterase type 5 (PDE5) inhibitor therapy.
Aim: To establish an evidence-based position on treatment goals in ED, including the role of erection hardness, with the potential to improve self-esteem, confidence, and overall sexual and relationship satisfaction.
Main outcome measure: The target of ED therapy is optimization of a rigid erectile response, as assessed by the 4-point Erection Hardness Score (EHS). Methods. An international panel of experts in urology, psychology, and primary care convened to evaluate retrospective data from worldwide phase 2, 3, and 4 clinical trials, involving over 10,000 men with ED, as well as data from recent prospective studies, concerning the role of erection hardness in defining the response to treatment with PDE5 therapy.
Results: Significant positive correlations were found between EHS and the Quality of Erection Questionnaire and the International Index of Erectile Function (IIEF) erectile function domain score and other IIEF measures. Significant positive correlations were also found between erection hardness and psychosocial measures such as self-esteem, confidence, and relationship satisfaction (assessed by the Self-Esteem And Relationship questionnaire), and satisfaction with medical treatment (assessed by the Erectile Dysfunction Inventory of Treatment Satisfaction). A shift in most frequent erection from EHS 3 (hard enough for penetration but not fully hard) at baseline to EHS 4 (completely hard and fully rigid) at the end of treatment was accompanied by significant improvements in intercourse and relationship satisfaction, psychosocial benefits, and satisfaction with ED treatment.
Conclusions: Support is found for monitoring and treating patients with ED to their full erectile potential. Quantitative assessment of erection hardness in clinical practice will lead to improved outcomes in overall sexual experience and optimal treatment satisfaction.
Similar articles
-
Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027. Urology. 2006. PMID: 17011373 Review.
-
Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.J Sex Med. 2008 Aug;5(8):1955-64. doi: 10.1111/j.1743-6109.2008.00879.x. Epub 2008 Jun 28. J Sex Med. 2008. PMID: 18564150 Clinical Trial.
-
Quality of erections in men treated with flexible-dose sildenafil for erectile dysfunction: multicenter trial with a double-blind, randomized, placebo-controlled phase and an open-label phase.J Sex Med. 2008 Mar;5(3):726-34. doi: 10.1111/j.1743-6109.2007.00701.x. Epub 2007 Dec 17. J Sex Med. 2008. PMID: 18086165 Clinical Trial.
-
Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction.J Sex Med. 2004 Sep;1(2):185-92. doi: 10.1111/j.1743-6109.2004.04027.x. J Sex Med. 2004. PMID: 16422973 Clinical Trial.
-
Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.Int J Impot Res. 2007 Jul-Aug;19(4):398-406. doi: 10.1038/sj.ijir.3901549. Epub 2007 Mar 15. Int J Impot Res. 2007. PMID: 17361232 Review.
Cited by
-
Evaluation of the sensitivity of different doses of vasoactive drugs in diagnosing erectile dysfunction in impotent patients: a prospective case-control study.Cent European J Urol. 2021;74(1):109-115. doi: 10.5173/ceju.2021.00042.R1. Epub 2021 Feb 6. Cent European J Urol. 2021. PMID: 33976925 Free PMC article.
-
The design, implementation, and impact of an automated patient-reported outcome data collection and adverse event surveillance tool: a randomized trial.BMC Health Serv Res. 2023 Nov 20;23(1):1277. doi: 10.1186/s12913-023-10231-1. BMC Health Serv Res. 2023. PMID: 37986191 Free PMC article. Clinical Trial.
-
Significance of erection hardness score as a diagnostic tool to assess erectile function recovery in Japanese men after robot-assisted radical prostatectomy.J Robot Surg. 2016 Sep;10(3):221-6. doi: 10.1007/s11701-016-0571-2. Epub 2016 Mar 19. J Robot Surg. 2016. PMID: 26994775
-
Recovery of the hibernating cavernosum by penile revascularization.Arab J Urol. 2024 Mar 23;22(4):212-218. doi: 10.1080/20905998.2024.2333675. eCollection 2024. Arab J Urol. 2024. PMID: 39355789 Free PMC article.
-
Treatment expectations of men with ED and their female partners: an exploratory qualitative study based on grounded theory.Int J Impot Res. 2015 Sep-Oct;27(5):167-72. doi: 10.1038/ijir.2015.9. Epub 2015 Jun 11. Int J Impot Res. 2015. PMID: 26063159
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical